BRPI0510019A - amidas de ácido tiofenocarboxìlico substituìdas, sua preparação e seu uso como medicamento - Google Patents
amidas de ácido tiofenocarboxìlico substituìdas, sua preparação e seu uso como medicamentoInfo
- Publication number
- BRPI0510019A BRPI0510019A BRPI0510019-4A BRPI0510019A BRPI0510019A BR PI0510019 A BRPI0510019 A BR PI0510019A BR PI0510019 A BRPI0510019 A BR PI0510019A BR PI0510019 A BRPI0510019 A BR PI0510019A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- acid amides
- medicament
- thiophenecarboxylic acid
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
AMIDAS DE áCIDO TIOFENOCARBOXìLICO SUBSTITUìDAS, SUA PREPARAçãO E SEU USO COMO MEDICAMENTO. O objeto da presente invenção são novas amidas de ácido tiofeno-2-carboxílico substituídas da fórmula geral (I), na qual A e R¬ ¹¬ até R¬ 8?¬ são definidos tal como na reivindicação 1, seus tautómeros, seus enantiómeros, seus diastereómeros, suas misturas e seus sais, especialmente seus sais fisiologicamente toleráveis com ácidos ou bases inorgânicos ou orgânicos, as quais apresentam valiosas características.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04011384 | 2004-05-13 | ||
EP04018807 | 2004-08-07 | ||
PCT/EP2005/004975 WO2005111029A1 (de) | 2004-05-13 | 2005-05-07 | Neue substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0510019A true BRPI0510019A (pt) | 2007-09-25 |
Family
ID=34969085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510019-4A BRPI0510019A (pt) | 2004-05-13 | 2005-05-07 | amidas de ácido tiofenocarboxìlico substituìdas, sua preparação e seu uso como medicamento |
Country Status (13)
Country | Link |
---|---|
US (1) | US7476663B2 (pt) |
EP (1) | EP1747217A1 (pt) |
JP (1) | JP2007537180A (pt) |
KR (1) | KR20070012552A (pt) |
AR (1) | AR048959A1 (pt) |
AU (1) | AU2005243535A1 (pt) |
BR (1) | BRPI0510019A (pt) |
CA (1) | CA2564207A1 (pt) |
IL (1) | IL179170A0 (pt) |
MX (1) | MXPA06013213A (pt) |
RU (1) | RU2006143842A (pt) |
TW (1) | TW200604178A (pt) |
WO (1) | WO2005111029A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007537179A (ja) * | 2004-05-13 | 2007-12-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換チオフェン−2−カルボン酸アミド、その製法及び薬物としての使用 |
WO2005111014A1 (de) * | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel |
DE102004062544A1 (de) * | 2004-12-24 | 2006-07-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel |
PE20070171A1 (es) * | 2005-06-30 | 2007-03-08 | Boehringer Ingelheim Int | GLICINAMIDAS SUSTITUIDAS CON EFECTO ANTITROMBOTICO E INHIBIDOR DEL FACTOR Xa |
PE20081834A1 (es) * | 2006-12-31 | 2009-01-16 | Boehringer Ingelheim Int | Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos |
WO2009063028A2 (en) | 2007-11-15 | 2009-05-22 | Boehringer Ingelheim International Gmbh | Substituted amides, manufacturing and use thereof as medicaments |
WO2009119528A1 (ja) * | 2008-03-24 | 2009-10-01 | 武田薬品工業株式会社 | 複素環化合物 |
US20100168377A1 (en) * | 2008-12-29 | 2010-07-01 | Carter Technologies | Catalytic conversion of amide compounds to methyl ether polymers and methyl ether ladder polymers |
ITBO20090078A1 (it) | 2009-02-13 | 2010-08-14 | Consiglio Nazionale Ricerche | Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi |
US8278302B2 (en) | 2009-04-08 | 2012-10-02 | Boehringer Ingelheim International Gmbh | Substituted piperidines as CCR3 antagonists |
CA2752826A1 (en) * | 2009-04-20 | 2010-10-28 | OSI Pharmaceuticals, LLC | Preparation of c-pyrazine-methylamines |
AU2010362639B2 (en) * | 2010-10-18 | 2016-10-27 | Apotex Pharmachem Inc. | Processes for the preparation of Rivaroxaban and intermediates thereof |
US8912221B2 (en) * | 2010-12-27 | 2014-12-16 | Hoffmann-La Roche Inc. | Biaryl amide derivatives |
WO2012149102A1 (en) * | 2011-04-29 | 2012-11-01 | Glaxosmithkline Llc | Novel compounds as wip1 inhibitors |
GB201820166D0 (en) * | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
US11795147B2 (en) | 2019-08-26 | 2023-10-24 | Boehringer Ingelheim International Gmbh | Modulators of complex I |
US11691960B2 (en) | 2020-11-06 | 2023-07-04 | Boehringer Ingelheim International Gmbh | 2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
GB0030304D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
GB0030305D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
DE10063008A1 (de) | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
MY130373A (en) * | 2001-10-29 | 2007-06-29 | Malesci Sas | Linear basic compounds having nk-2 antagonist activity and formulations thereof |
US20040077635A1 (en) * | 2002-10-02 | 2004-04-22 | Qiao Jennifer X. | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor Xa inhibitors |
DE10254336A1 (de) * | 2002-11-21 | 2004-06-03 | Merck Patent Gmbh | Carbonsäureamide |
DE10301419A1 (de) * | 2003-01-16 | 2004-07-29 | Bayer Cropscience Ag | Spiroverbindungen |
-
2005
- 2005-05-07 MX MXPA06013213A patent/MXPA06013213A/es active IP Right Grant
- 2005-05-07 JP JP2007512051A patent/JP2007537180A/ja active Pending
- 2005-05-07 CA CA002564207A patent/CA2564207A1/en not_active Abandoned
- 2005-05-07 EP EP05747401A patent/EP1747217A1/de not_active Withdrawn
- 2005-05-07 RU RU2006143842/04A patent/RU2006143842A/ru not_active Application Discontinuation
- 2005-05-07 BR BRPI0510019-4A patent/BRPI0510019A/pt not_active IP Right Cessation
- 2005-05-07 WO PCT/EP2005/004975 patent/WO2005111029A1/de active Application Filing
- 2005-05-07 AU AU2005243535A patent/AU2005243535A1/en not_active Abandoned
- 2005-05-07 KR KR1020067026224A patent/KR20070012552A/ko not_active Application Discontinuation
- 2005-05-10 US US11/125,731 patent/US7476663B2/en active Active
- 2005-05-12 TW TW094115321A patent/TW200604178A/zh unknown
- 2005-05-13 AR ARP050101961A patent/AR048959A1/es unknown
-
2006
- 2006-11-09 IL IL179170A patent/IL179170A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005243535A1 (en) | 2005-11-24 |
RU2006143842A (ru) | 2008-08-20 |
US7476663B2 (en) | 2009-01-13 |
AR048959A1 (es) | 2006-06-14 |
TW200604178A (en) | 2006-02-01 |
WO2005111029A1 (de) | 2005-11-24 |
CA2564207A1 (en) | 2005-11-24 |
EP1747217A1 (de) | 2007-01-31 |
JP2007537180A (ja) | 2007-12-20 |
KR20070012552A (ko) | 2007-01-25 |
MXPA06013213A (es) | 2007-02-08 |
US20050277628A1 (en) | 2005-12-15 |
IL179170A0 (en) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510019A (pt) | amidas de ácido tiofenocarboxìlico substituìdas, sua preparação e seu uso como medicamento | |
BRPI0506988A (pt) | carboxamidas como inibidores de fator xa | |
BRPI0112986B8 (pt) | compostos azabicíclicos, processo para a sua preparação, bem como composições farmacêuticas compreendendo os ditos compostos | |
BRPI0509368A (pt) | antagonistas cgrp selecionados, processo para a sua fabricação bem como seu uso como medicamento | |
BR0315665A (pt) | Antagonistas de cgrp selecionados, processos para preparação dos mesmos, bem como uso dos mesmos como medicamento | |
BRPI0612580A8 (pt) | glicinamidas substituídas, processo para a sua preparação e uso da mesma como medicamentos | |
BR0315642A (pt) | Antagonistas de cgrp selecionados, processo para sua preparação, bem como seu uso como medicamento | |
BRPI0407387A (pt) | Derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona substituìdos por nitrogênio, processos para a sua preparação e sua aplicação com medicamento | |
BRPI0607577A2 (pt) | antagonistas cgrp, processo para sua preparação bem como seu uso como medicamento | |
BRPI0411862A (pt) | combinações de substáncias ativas com propriedades inseticidas e acaricidas | |
BRPI0507309A (pt) | derivados de ácido 7-fenilamino-4quinolon-3-carboxìlico, processos para produção e seu uso como medicamento | |
BRPI0415758A (pt) | combinações de substáncias ativas fungicidas sinergìsticas | |
BR0214975A (pt) | Derivados de fenila substituìdos | |
BR0317283A (pt) | Derivados heterocìclicos de flúor-glicosìdeo, medicamentos contendo estes compostos e seu uso | |
BR0313179A (pt) | Pró-drogas de (n-2-piridil-n-2-hidroxicarboniletil)-amida de ácido 1-metil-2-(4-amidinofenilaminometil)-benzimidazol-5-il -carboxìlico, sua preparação e seu emprego como medicamento | |
BRPI0911035A2 (pt) | ativadores de pirrolidinona glicoquinase | |
BRPI0507830A (pt) | derivados azabicìclicos, o respectivo processo de preparo e as composições farmacêuticas que os contêm | |
BRPI0510770A (pt) | derivados de fluorglicosìdeos de pirazóis, medicamentos contendo esses compostos e seu uso | |
BRPI0410995A (pt) | derivados de n-alquinil-2-(arilóxi substituìdo)alquiltioamida como fungicidas | |
BRPI0617167B8 (pt) | sulfonilpirróis como inibidores de hdac's, seu uso, composição farmacêutica e combinação | |
BRPI0416276A (pt) | lactames macrocìclicos e uso farmacêutico dos mesmos | |
BR0017063A (pt) | Piperidinas substituìdas, composições farmacêuticas contendo estes compostos e processos para prepará-las | |
BR0311896A (pt) | Difenilazetidinonas substituìdas com grupos ácidos, processo para sua preparação, medicamentos contendo estes compostos e seu uso | |
BRPI0407507A (pt) | derivados de hexahidro-pirazino[1,2-a]pirimidin-4,7-diona, processos para sua preparação de sua aplicação como medicamento | |
BR0015147A (pt) | Ciclopropanos como cgrp-antagonistas, medicamentos contendo os ditos compostos e processo para a produção dos mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |